Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
Project Oncology®
Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
Benjamin Garmezy, MD
- Benjamin Garmezy, MD
What's Next for Urothelial Cancer Treatment?
What's Next for Urothelial Cancer Treatment?
Project Oncology®
What's Next for Urothelial Cancer Treatment?
Benjamin Garmezy, MD
- Benjamin Garmezy, MD
A Long-Term View of Cardiovascular Risk After Cancer Treatment
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Heart Matters
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Stephanie Dixon, MD, MPH
- Stephanie Dixon, MD, MPH
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Heart Matters
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Stephanie Dixon, MD, MPH
- Stephanie Dixon, MD, MPH
Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Project Oncology®
Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Kerry A. Rogers, MD
- Kerry A. Rogers, MD
Moving Beyond Chemotherapy in Mantle Cell Lymphoma Care
Moving Beyond Chemotherapy in Mantle Cell Lymphoma Care
Project Oncology®
Moving Beyond Chemotherapy in Mantle Cell Lymphoma Care
Jonathon Cohen, MD, MS
- Jonathon Cohen, MD, MS
How Myeloid Mutations in ALL Inform Treatment Decisions
How Myeloid Mutations in ALL Inform Treatment Decisions
Project Oncology®
How Myeloid Mutations in ALL Inform Treatment Decisions
Caner Saygin, MD
- Caner Saygin, MD
Closing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Closing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Clinician's Roundtable
Closing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Peter Buch, MD, FACG, AGAF, FACP; Mallik Greene, PhD
- Peter Buch, MD, FACG, AGAF, FACP
- Mallik Greene, PhD
- Jordan Karlitz, MD

Medical News

Medical News
Levofloxacin Prophylaxis Failure Tied to Resistance and PK/PD
09/10/2026
Read more
Medical News
More Negative Sentinel Nodes Didn’t Improve Breast Cancer Outcomes
09/04/2026
Read more
Medical News
Real-World ALK TKI Outcomes in Metastatic NSCLC
09/04/2026
Read more
Medical News
Predicting Pneumonia After Brain Tumor Surgery
09/04/2026
Read more

CME/CE

Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
MinuteCE®
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
Komal Jhaveri, MD, FACP; Virginia Kaklamani, MD, DSc
0.50 program credits
- Komal Jhaveri, MD, FACP
- Virginia Kaklamani, MD, DSc
0.50 program credits
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
MinuteCE®
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
Virginia Kaklamani, MD, DSc
0.50 program credits
- Virginia Kaklamani, MD, DSc
0.50 program credits
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
CME/CE Virtual Event
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 24, 2026
06:00 PM - 07:00 PM ET
1.00 credit
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
MinuteCE®
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
Natalie S. Callander, MD
0.75 program credits
- Natalie S. Callander, MD
0.75 program credits

Clinical Practice

Moving Toward Biomarker-Driven Care in Bladder Cancer
Moving Toward Biomarker-Driven Care in Bladder Cancer
Project Oncology®
Moving Toward Biomarker-Driven Care in Bladder Cancer
Benjamin Garmezy, MD
- Benjamin Garmezy, MD
Supportive Care During and After CLL Treatment: What to Prioritize
Supportive Care During and After CLL Treatment: What to Prioritize
Project Oncology®
Supportive Care During and After CLL Treatment: What to Prioritize
Kerry A. Rogers, MD
- Kerry A. Rogers, MD
Adapting CV Risk Reduction Strategies for Cancer Survivorship
Adapting CV Risk Reduction Strategies for Cancer Survivorship
Heart Matters
Adapting CV Risk Reduction Strategies for Cancer Survivorship
Stephanie Dixon, MD, MPH
- Stephanie Dixon, MD, MPH
Making the Most of WCLC 2026: A Guide for Early-Career Professionals
Making the Most of WCLC 2026: A Guide for Early-Career Professionals
Project Oncology®
Making the Most of WCLC 2026: A Guide for Early-Career Professionals
Triparna Sen, PhD
- Triparna Sen, PhD

Programs

Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Project Oncology®
Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Jonathon B. Cohen, MD, MS
- Jonathon B. Cohen, MD, MS
Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Project Oncology®
Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Caner Saygin, MD
- Caner Saygin, MD
MinuteCE®
Oral SERDs and PROTACs in ER+/HER2− mBC: Testing Smarter, Treating Better
Komal Jhaveri, MD, FACP; Virginia Kaklamani, MD, DSc
0.50 credits 4 episodes
- Komal Jhaveri, MD, FACP
- Virginia Kaklamani, MD, DSc
0.50 credits 4 episodes
Closing the Evidence Gap in Metastasis-Directed Therapy for mBC
Closing the Evidence Gap in Metastasis-Directed Therapy for mBC
Project Oncology®
Closing the Evidence Gap in Metastasis-Directed Therapy for mBC
Lajos Pusztai, MD, DPhil
- Lajos Pusztai, MD, DPhil